Video
Author(s):
The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.
The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.
Jeffrey Saver, MD, FAHA, FAAN, from the Geffen School of Medicine at UCLA discussed the results of the study and the impact of the development of the therapy on the treatment of stroke at the International Stroke Conference in Nashville.